- Home
- FNB vs MRUS Comparison
FNB vs MRUS Comparison
Compare FNB & MRUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FNB
- MRUS
- Stock Information
- Founded
- FNB 1864
- MRUS 2003
- Country
- FNB United States
- MRUS Netherlands
- Employees
- FNB N/A
- MRUS N/A
- Industry
- FNB Major Banks
- MRUS Biotechnology: Pharmaceutical Preparations
- Sector
- FNB Finance
- MRUS Health Care
- Exchange
- FNB Nasdaq
- MRUS Nasdaq
- Market Cap
- FNB 5.6B
- MRUS 5.1B
- IPO Year
- FNB N/A
- MRUS 2016
- Fundamental
- Price
- FNB $15.61
- MRUS $95.99
- Analyst Decision
- FNB Strong Buy
- MRUS Buy
- Analyst Count
- FNB 9
- MRUS 18
- Target Price
- FNB $18.39
- MRUS $93.72
- AVG Volume (30 Days)
- FNB 7.0M
- MRUS 1.3M
- Earning Date
- FNB 10-16-2025
- MRUS 10-31-2025
- Dividend Yield
- FNB 3.08%
- MRUS N/A
- EPS Growth
- FNB 28.48
- MRUS N/A
- EPS
- FNB 1.40
- MRUS N/A
- Revenue
- FNB $1,587,400,000.00
- MRUS $56,606,000.00
- Revenue This Year
- FNB $17.82
- MRUS $52.81
- Revenue Next Year
- FNB $8.12
- MRUS N/A
- P/E Ratio
- FNB $11.14
- MRUS N/A
- Revenue Growth
- FNB 6.34
- MRUS 57.54
- 52 Week Low
- FNB $10.88
- MRUS $33.19
- 52 Week High
- FNB $17.70
- MRUS $96.28
- Technical
- Relative Strength Index (RSI)
- FNB 46.22
- MRUS 77.13
- Support Level
- FNB $15.21
- MRUS $95.65
- Resistance Level
- FNB $16.42
- MRUS $96.06
- Average True Range (ATR)
- FNB 0.38
- MRUS 0.37
- MACD
- FNB -0.03
- MRUS -0.49
- Stochastic Oscillator
- FNB 29.88
- MRUS 80.39
About FNB F.N.B. Corporation
F N B Corp provides a full range of financial services, principally to consumers, corporations, governments and small- to medium-sized businesses. It has three reportable business segments: Community Banking, Wealth Management and Insurance. The majority of revenue is from the Community banking segment. It offers commercial & consumer banking services. Commercial banking solutions include corporate banking, small business banking, investment real estate financing, business credit, capital markets & lease financing. Consumer banking products & services include deposit products, mortgage lending, & consumer lending & a complete suite of mobile & online banking services.
About MRUS Merus N.V.
Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.